Yang Meng
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cell death mechanisms and regulation
Papers in
-
- RNA modifications and cancer 8
- Cell death mechanisms and regulation 7
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 5
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 7
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Liang Xu (8 shared papers)Jeffrey DeSano (5 shared papers)Theodore S. Lawrence (7 shared papers)Qing Ji (4 shared papers)Min Zhang (2 shared papers)Xinbao Hao (3 shared papers)Daiming Fan (2 shared papers)Wenhua Tang (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)BMC Cancer (2 papers)Molecular Genetics and Genomics (2 papers)Journal of Cell Science (2 papers)Frontiers in Endocrinology (2 papers)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Yang Meng
64 papers receiving 2.6k citations
Yang Meng's Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 1.2k
- Molecular Biology 1.9k
- Oncology 532
- Toxicology 57
- Complementary and alternative medicine 110
Countries citing papers authored by Yang Meng
This map shows the geographic impact of Yang Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Meng more than expected).
Fields of papers citing papers by Yang Meng
This network shows the impact of papers produced by Yang Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Meng. The network helps show where Yang Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells Hit paper breakdown → | 2009 | 558 |
| 2 | 2008 | 338 | |
| 3 | 2010 | 187 | |
| 4 | 2008 | 167 | |
| 5 | 2010 | 130 | |
| 6 | 2015 | 119 | |
| 7 | 2013 | 111 | |
| 8 | 2019 | 77 | |
| 9 | 2017 | 73 | |
| 10 | 2009 | 66 | |
| 11 | 2010 | 64 | |
| 12 | 2022 | 62 | |
| 13 | 2013 | 58 | |
| 14 | Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. | 2011 | 49 |
| 15 | 2019 | 48 | |
| 16 | 2018 | 47 | |
| 17 | 2022 | 42 | |
| 18 | 2019 | 40 | |
| 19 | 2022 | 40 | |
| 20 | 2022 | 27 |
About Yang Meng
Yang Meng is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Immunology, having authored 72 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), RNA modifications and cancer (8 papers), Cell death mechanisms and regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Robotic Path Planning Algorithms (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.9k citations), Oncology (532 citations), Toxicology (57 citations) and Complementary and alternative medicine (110 citations). Yang Meng has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Liang Xu, Jeffrey DeSano, Theodore S. Lawrence, Qing Ji, Min Zhang, Xinbao Hao, Daiming Fan, Wenhua Tang, Yao Dai and Debing Xiang. Their work appears in journals such as Molecular Cancer Therapeutics, BMC Cancer, Molecular Genetics and Genomics, Journal of Cell Science and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.